Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Mepacrine

Next Previous
Drug Profile

Mepacrine

Alternative Names: 9-aminoacridine; Atabrine dihydrochloride; CBL 0102; Curaxin CBL0102; Quinacrine; SN 390

Latest Information Update: 02 Sep 2021

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Cleveland BioLabs
  • Developer Incuron; National Cancer Institute (USA)
  • Class Aminoacridines; Antimalarials; Antineoplastics; Antiprotozoals; Small molecules
  • Mechanism of Action SSRP1 protein inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    Yes - Liver cancer
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Prostate cancer
  • No development reported Liver cancer; Liver metastases; Non-small cell lung cancer

Most Recent Events

  • 01 Sep 2021 Cytocom is now called Statera BioPharma
  • 28 Jul 2021 Cytocom has been merged with Cleveland BioLabs to form Cytocom
  • 28 May 2018 No recent reports of development identified for phase-I development in Liver metastases in Russia (PO)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top